TABLE 1.
Effect of azurin proteins on Toxoplasma growth as measured by plaque assaya
| Sample | No. of plaques |
|---|---|
| Control, untreated | >30 |
| Laz, 0.1 μM | 30 |
| Laz, 1.0 μM | 10 |
| Laz, 5.0 μM | 3 |
| Laz, 10 μM | 3 |
| Az, 0.1 μM | >30 |
| Az, 1.0 μM | 15 |
| Az, 5.0 μM | 15 |
| Az, 10 μM | 10 |
a
Toxoplasma-infected HFF monolayers were treated with increasing concentrations of azurin (Az) or azurin-like (Laz) proteins for 5 days and then processed for plaque assay (23). The number of parasite plaques in each flask is shown. The data shown are the results from one of three independent experiments that produced similar results.